What is CTT Pharmaceutical Holdings, Inc. (CTTH) stock price today?

CTT Pharmaceutical Holdings, Inc. (CTTH) is currently trading at $0.07, up 8.02% today.

What is CTTH P/E ratio?

CTT Pharmaceutical Holdings, Inc.'s P/E ratio is -26.40. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is CTTH return on equity (ROE)?

CTT Pharmaceutical Holdings, Inc.'s return on equity (ROE) is -242.12%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is CTT Pharmaceutical Holdings, Inc.'s market cap?

CTT Pharmaceutical Holdings, Inc. has a market capitalization of $1.41M.

OTC · Medical - Pharmaceuticals

CTT Pharmaceutical Holdings, Inc. (CTTH) Stock

$0.07 +8.02% OTC: CTTH Healthcare

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment.

Valuation

Metric	Value
Price	$0.07
Market Cap	$1.41M
P/E Ratio	-26.40
P/B Ratio	94.41
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.10
52-Week Low	$0.03
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-242.12%
ROA	-206.81%
ROCE	-280.27%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.46
Current Ratio	0.20

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$0	$0	$0	$0	$0
Net Profit	$0	$0	$0	$0	$0
EPS	$0.00	$0.00	$0.00	$0.00	$0.00
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$0	$0	$0	$0	$0
Total Liabilities	$0	$0	$0	$0	$0
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$0	$0	$0	$0

Latest News

CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products ACCESS Newswire · Jun 22, 2026 CTT Pharma Signs LOI with European Company ACCESS Newswire · Jun 17, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-1.0M	$0	$0	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.46
EV / EBITDA	-13.02
FCF Yield	-4.48%
Quick Ratio	0.20
Interest Coverage	-57.73
Return 1Y	94.12%
Return 3Y	560.00%
Return 5Y	—

Ownership

Insiders Held50.32%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BINPBionoid Pharma, Inc.	$0.03	+0.00%	-3.53	$1.62M	0.00%
BMCSBioTech Medics, Inc.	$0.00	—	-13.86	$41071	0.00%
BMMJBody and Mind Inc.	$0.00	—	-0.11	$29537	0.00%
EDXCEndexx Corporation	$0.00	—	-0.02	$57185	0.00%
GXXYGalexxy Holdings, Inc.	$0.00	—	-195.15	$369605	0.00%

About CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.

CTT Pharmaceutical Holdings, Inc. is headquartered in US.

CTT Pharmaceutical Holdings, Inc. (CTTH) stock trades at $0.07 with a market capitalization of $1.41M. The stock is valued at a negative price-to-earnings (P/E) ratio of -26.40, reflecting a net loss over the last twelve months, price-to-book of 94.41, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.03 and $0.10, and currently trades 30.0% below its 52-week high.

On profitability, CTT Pharmaceutical Holdings, Inc. generates a return on equity (ROE) of -242.12% (negative, reflecting a net loss), return on capital employed of -280.27%.

Official website: www.cttpharmaceuticals.com